Integrated Mendelian Randomization and Single-Cell Transcriptomics Reveal T Cell Immune Mechanisms in Systemic Lupus Erythematosus–Bladder Cancer Comorbidity
Life · 21.08.2026 · 16 (8) · 1381
DOI: 10.3390/life16081381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 21.08.2026. Verfasst von Desheng Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, West China Hospital, Sichuan University, Chengdu 610041, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu Science and Technology Bureau.
Abstract (Originalsprache)
Objective
Patients with systemic lupus erythematosus (SLE) exhibit elevated malignancy risk, with increased bladder cancer incidence. This study integrated Mendelian randomization (MR) with single-cell sequencing (scRNA-seq) to nominate exploratory prioritized candidate genes in SLE–bladder cancer comorbidity and their T cell regulatory roles.
Methods
Single-cell datasets for SLE (GSE266852) and bladder cancer (GSE222315) were retrieved from GEO. Quality control, clustering, and annotation were performed using Seurat. T cell differentially expressed genes were intersected for bidirectional two-sample MR using IEU Open GWAS statistics. Heterogeneity, pleiotropy, and sensitivity analyses assessed robustness. GeneMANIA, miRNA databases, and CTD were used for network and functional analyses. Wilcoxon tests and Monocle 2 were used to characterize expression and T cell differentiation trajectories.
Results
Cross-disease intersection nominated 1010 candidate genes. In an exploratory MR screen (uncorrected p < 0.05), four candidate genes were nominated (GBP3, LMAN1, SLC40A1, MIS18BP1); none survived FDR correction in both directions. At the uncorrected threshold, LMAN1 showed a shared risk direction (OR > 1) and MIS18BP1 a protective direction (OR < 1). Both showed significant T cell differential expression (p < 0.001) and elevated late differentiation expression. LMAN1 was involved in COPII vesicle transport; MIS18BP1 in CENP-A chromatin assembly. Twenty high-confidence miRNAs targeted each gene. CTD indicated liver injury associations and cisplatin/cyclosporine interactions.
Conclusions
LMAN1 and MIS18BP1 are proposed as hypothesis-generating exploratory candidate genes in SLE–bladder cancer comorbidity, potentially involved in immune dysregulation through T cell terminal differentiation modulation. This study provides preliminary evidence suggestive of autoimmune–malignancy comorbidity mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
- Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Förderung
- Chengdu Science and Technology Bureau
Zitieren
APA
Zhang, D., Ren, H., Bai, Y., & Han, P. (2026). Integrated Mendelian Randomization and Single-Cell Transcriptomics Reveal T Cell Immune Mechanisms in Systemic Lupus Erythematosus–Bladder Cancer Comorbidity. Life, 16(8), 1381. https://doi.org/10.3390/life16081381
Vancouver
Zhang D, Ren H, Bai Y, Han P. Integrated Mendelian Randomization and Single-Cell Transcriptomics Reveal T Cell Immune Mechanisms in Systemic Lupus Erythematosus–Bladder Cancer Comorbidity. Life. 2026;16(8):1381. doi:10.3390/life16081381
BibTeX
@article{Zhang2026,
author = {Zhang, Desheng and Ren, Huan and Bai, Yunjin and Han, Ping},
title = {Integrated Mendelian Randomization and Single-Cell Transcriptomics Reveal T Cell Immune Mechanisms in Systemic Lupus Erythematosus–Bladder Cancer Comorbidity},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1381},
doi = {10.3390/life16081381}
}
EUVIMED